社区参与研究以改善帕金森病的种族多样性和健康平等
Eunyoung Kang1,2,3, Dominique Woodhouse4, Kandace Davis4
1UTHealth Houston Institute for Implementation Science, The University of Texas Health Science Center at Houston School of Public Health, Houston, TX, USA.
Journal of clinical and translational science
|October 20, 2025
概括
社区参与 (CE) 工作室有效地参与了黑人或非洲裔美国人 (AA) 在帕金森病中.
科学领域:
- 基于社区的参与式研究.
- 在帕金森病的健康差异.
- 文化上适当的医疗保健干预措施
背景情况:
- 患有帕金森病 (PD) 的黑人或非洲裔美国人 (AA) 面临着严重的健康差异,在研究中代表性不足.
- 关于从患者,护理合作伙伴和提供者的角度加强AA对PD护理和研究的参与,存在有限的指导.
- 这项研究解决了文化上适当和包容性PD研究和护理策略的需要.
研究的目的:
- 描述社区参与 (CE) 工作室的实用性,以告知文化上适当和包容的PD研究.
- 检查影响AA参与帕金森病相关活动的因素.
- 改善PD研究与AA社区之间的协调.
主要方法:
- 进行了三个社区参与 (CE) 研究,与各种利益相关者群体合作.
- 参与者包括患有PD的AA个人,护理合作伙伴和医疗保健提供者.
- 总参与者:18人 (第1工作室6人,第2工作室8人,第3工作室4人).
主要成果:
- CE工作室为计划中的PD项目的设计 (文化适当性) 和实施 (可访问性) 提供了信息.
- 确定了关键利益相关者,以加强社区参与和调整研究.
- 突出了影响AA参与的多方面的因素:环境,生物,社会文化和行为领域.
结论:
- 社区参与 (CE) 工作室为了解帕金森病研究中的AA观点提供了一种可行的和有价值的方法.
- 对社区观点的深入探索可以识别参与障碍,并完善PD护理的文化适当性.
- 利用社区洞察力对于改善PD研究包容性和对AA人群的护理提供至关重要.
相关概念视频
Parkinson's Disease: Treatment
972
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
972
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Community Based Intervention
270
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
270
Restorative Care
2.3K
Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
2.3K
Peripheral Artery Disease III: Interprofessional Care
237
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
237
Alzheimer's Disease: Treatment
811
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
811


